A proposed $100,000 H-1B visa fee threatens to worsen healthcare shortages in rural America by limiting access to foreign-trained doctors and essential medical staff.
Browsing: Health
Rep. Ami Bera enters the final quarter with $2 million cash-on-hand, showcasing his electoral strength, bipartisan leadership, and continued focus on healthcare and foreign policy.
President Donald Trump announced a partnership with EMD Serono to make IVF medications up to 84% cheaper, improving access to fertility treatments nationwide.
Indian American surgeon to leverage AI power to deepen ASPS’s engagement with domestic and international members
Former Indian American Surgeon General to help build a healthier digital landscape for children and families everywhere
OpenAI CEO Sam Altman announced that ChatGPT will soon relax safety restrictions, introducing friendlier, more human-like, and adults-only erotic features for verified users by year-end.
Google faces backlash after asking U.S. employees to share personal data with AI tool Nayya for health benefits, sparking concerns over privacy, consent, and data governance.
Pharma shares climbed up to 4% on Oct. 9 after a report said President Donald Trump isn’t planning to impose tariffs on generic drugs from foreign countries.
Google faces employee backlash after reports that accessing health benefits requires sharing personal data with third-party AI tool Nayya, raising privacy and consent concerns.
It looks like Johnson & Johnson will have to part with nearly a billion dollars. A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma
Qualtrics is set to acquire healthcare survey firm Press Ganey Forsta in a $6.75 billion deal, combining AI analytics with deep healthcare data networks.
The U.S. faces a partial government shutdown as political deadlock over healthcare and spending forces federal furloughs, economic uncertainty, and threats of mass layoffs.
Rite Aid, one of America’s oldest pharmacy chains, has officially shut down after decades of service, following bankruptcy, opioid lawsuits, and mounting financial struggles.
Oracle founder Larry Ellison pledges to donate 95% of his $373 billion wealth, focusing on long-term, impact-driven philanthropy through science, healthcare, climate, and AI innovation.
With a U.S. government shutdown looming, Trump’s clash with Congress over healthcare funding and budget priorities risks halting federal services and escalating political tensions before Oct. 1.
Are you prepared to live a longer and healthier life? Discover practical ways to improve wellness, extend longevity, and embrace habits that support vitality every day.
First-of-its-kind research aboard Axiom Mission 4 shows diabetes monitoring tools can function reliably in space, signaling new possibilities for inclusive space travel and remote healthcare.
Trump escalates tariffs on drugs, metals, trucks, and furniture under national security grounds, reshaping global trade while pressuring allies like India to navigate oil import challenges.
Eli Lilly will invest $6.5 billion to build a state-of-the-art biomanufacturing facility in Houston, creating 600 jobs and boosting production of advanced therapies.
NutrifyToday co-founder opening a Somerset, New Jersey office to accelerate the Indo–US nutraceutical corridor
The WHO clarifies there is no conclusive evidence linking Tylenol use in pregnancy to autism, urging reliance on medical advice over unverified claims.
A federal judge ordered the Trump administration to restore $500 million in UCLA medical research grants, safeguarding vital studies and reinforcing UC’s stance against political interference.
Dr. Bijoy Sagar of Bayer outlines how responsible, AI-first innovation in pharma and agriculture can drive efficiency, equity, and transformative change for “health for all, hunger for none.”
Patient Square Capital to acquire Premier for $2.6 billion, taking it private to expand healthcare supply chain, technology, and advisory services.
The U.S. has revoked visas of Indian executives tied to fentanyl precursor exports, signaling tougher scrutiny on India’s chemical sector amid global efforts to curb opioid trafficking.